Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group.
about
Role of phosphodiesterase-5 inhibitors in heart failure: emerging data and concepts.Post-transplant survival after lowering fixed pulmonary hypertension using left ventricular assist devices.Determinants of ventilatory efficiency in heart failure: the role of right ventricular performance and pulmonary vascular tone.Initial Experience with Sildenafil, Bosentan, and Nitric Oxide for Pediatric Cardiomyopathy Patients with Elevated Pulmonary Vascular Resistance before and after Orthotopic Heart TransplantationSaudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary hypertension due to left heart disease.Pulmonary hypertension secondary to left ventricular systolic dysfunction: contemporary diagnosis and managementPulsatile left ventricular assist device support as a bridge to decision in patients with end-stage heart failure complicated by pulmonary hypertension.An official American Thoracic Society Statement: pulmonary hypertension phenotypesPulmonary Arterial Capacitance Is an Important Predictor of Mortality in Heart Failure With a Preserved Ejection FractionSildenafil in the treatment of pulmonary hypertension.Diagnosis and management of pulmonary hypertension associated with left ventricular diastolic dysfunction.Effect of bosentan on pulmonary hypertension secondary to systolic heart failure.Left ventricular dysfunction with pulmonary hypertension: part 2: prognosis, noninvasive evaluation, treatment, and future research.ULTIMATE-SHF trial (UdenafiL Therapy to Improve symptoMAtology, exercise Tolerance and hEmodynamics in patients with chronic systolic heart failure): study protocol for a randomized, placebo-controlled, double-blind trialWHO's in second?: A practical review of World Health Organization group 2 pulmonary hypertension.Pulmonary vascular response patterns during exercise in left ventricular systolic dysfunction predict exercise capacity and outcomes.Left ventricular assist device to avoid heart-lung transplant in an adolescent with dilated cardiomyopathy and severely elevated pulmonary vascular resistancePulmonary Hypertension in Heart Failure Patients Presenting at OAUTHC, Ile-Ife, Nigeria.PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support.Inhaled epoprostenol for the treatment of pulmonary arterial hypertension in critically ill adults.Pulmonary vasodilation in acute and chronic heart failure: empiricism and evidence.Pulmonary hypertension related to left-sided cardiac pathology.Pulmonary hypertension and right ventricular function in advanced heart failure.Review of inhaled nitric oxide in the pediatric cardiac surgery setting.Inhaled nitric oxide applications in paediatric practice.Postoperative care of the transplanted patientControversies in pulmonary hypertension due to left heart diseaseRight heart catheterisation: indications and interpretation.Treatment and Prognosis of Pulmonary Hypertension in the Left Ventricular Assist Device Patient.Pulmonary Hypertension in the Era of Mechanical Circulatory SupportImpact of postoperative pulmonary hypertension on outcome after heart transplantation.Treatment of secondary pulmonary hypertension with bosentan after left ventricular assist device implantation.What is the prognostic significance of pulmonary hypertension in heart failure?Comparison of drugs for pulmonary hypertension reversibility testing: A meta-analysis.Fall in pulmonary vascular resistance in patients awaiting heart transplantation.Early right ventriculo-arterial uncoupling in borderline pulmonary hypertension on experimental heart failure.Reversible pulmonary hypertension in heart transplant candidates--pretransplant evaluation and outcome after orthotopic heart transplantation.Pilot assessment of the response of several pulmonary hemodynamic variables to sublingual sildenafil in candidates for heart transplantation.Prognostic value of mean pulmonary artery pressure in the stable phase after heart transplantation.Haemodynamic effects of an acute vasodilator challenge in heart failure patients with reduced ejection fraction and different forms of post-capillary pulmonary hypertension.
P2860
Q30575578-A45680E9-47A7-4BE8-8C7F-844FE6ED7908Q33272921-A0529056-4C34-4D2E-9821-A369CE313241Q33591972-6A4D18C1-0698-40C9-991B-28EB882B340CQ33717842-3B244FFD-F234-43B0-B15F-71869F26E994Q33965866-3F3A7139-D3C7-4349-80EF-E2085F6B28B3Q34525179-5C8492C1-9DC8-485F-A579-27CC7586FE69Q34733039-1090AE5A-3FD1-49EA-88CB-62A0F01A38A2Q34919733-D45BB015-6BA2-4312-996D-8DD1329D6F3BQ35954669-210517A1-CB9D-4471-ADEF-0EDF9BD1FAF1Q36013070-E88ECC3F-D1AD-4F14-8DBD-D176DB93150CQ36108045-3BF61160-A8D6-4867-9C66-47ACA0CED08FQ36302304-DC7CDE7D-B6DC-4F9B-B94F-69DBA45BED05Q36868978-AE43C2C4-E7A4-4528-9D29-0071640CBD8DQ36958494-73CC9D13-C247-420D-98B9-F19636CCE00FQ37073847-AF1F450C-8325-42D9-8C05-B4588D0074D6Q37086877-06DEC68A-6BE3-4405-A4F8-8532E04E6DA8Q37171534-DE98E4C2-CBD2-4F9A-A48B-5140289DDD2FQ37409709-0D87346E-07C9-4AEA-A787-F050BE01115CQ37727128-8FD6D043-17D0-45FC-BF3A-CE0D65336B23Q37767429-77710503-F65E-46C9-A0E8-B81D9D35DD72Q37873778-31BF5655-F694-4004-A5F4-108019F4188BQ37887514-70EC9963-813D-4C1F-8EBD-573240C17E5BQ37905953-6DFD1244-4021-4289-AE1C-152A79689320Q37980691-4EF36AB0-E3EF-4623-B623-DDE4825EF602Q37988497-8B5AD46D-111F-4812-A894-91ABE8095F61Q38006699-FD9E2FE5-F2CC-45D9-991F-DB9EFBEEC695Q38364200-28079E6D-D3A1-469F-B11F-6114C153ECE3Q38678609-379621D0-1C4B-4504-96BC-BF74A69BBA81Q38848544-E1BBFA97-C77E-4FCC-980E-A88703395928Q38904366-4B628405-5788-45A3-8687-B2C769BE14DAQ40281536-398C56BA-7A78-443F-ADCD-8A1056D4D907Q41249797-07BBE331-C521-4D46-BBF6-CEB4301A5863Q42549664-DD573F88-6B77-4ADA-A216-A7331639B48AQ42577593-EDE8950B-51DA-4690-B63D-3A982DF48D14Q42578070-77DCEFD6-40F8-46FC-9949-4EEA95C7F0C5Q42944906-F166B66A-F4B2-423D-86CF-89935B41C9ADQ44648439-3F7EF0D6-F058-454C-B940-DEC87D1E7CDFQ45011973-7F43270E-C0F4-4E7E-86FE-E42175921738Q47348661-45C5F241-D28C-47BA-B29A-1FB7B09B8ABBQ47708834-E944B4B3-36CD-4CFA-9195-6213553A6F45
P2860
Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group.
description
1992 nî lūn-bûn
@nan
1992 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Influence of preoperative pulm ...... in defining a high risk group.
@ast
Influence of preoperative pulm ...... in defining a high risk group.
@en
Influence of preoperative pulm ...... in defining a high risk group.
@nl
type
label
Influence of preoperative pulm ...... in defining a high risk group.
@ast
Influence of preoperative pulm ...... in defining a high risk group.
@en
Influence of preoperative pulm ...... in defining a high risk group.
@nl
prefLabel
Influence of preoperative pulm ...... in defining a high risk group.
@ast
Influence of preoperative pulm ...... in defining a high risk group.
@en
Influence of preoperative pulm ...... in defining a high risk group.
@nl
P1476
Influence of preoperative pulm ...... in defining a high risk group.
@en
P2093
Costard-Jäckle A
P356
10.1016/0735-1097(92)90050-W
P407
P577
1992-01-01T00:00:00Z